Younger adults with difficult-to-treat epilepsy may have early signs of chronic traumatic encephalopathy in their brain tissue, but it appears to be uncommon, according to a small, preliminary study published in the January ...
Jan 10, 2018
0
20
(HealthDay)—Levetiracetam performs better than carbamazepine and lamotrigine for individuals with partial seizures, according to a review and meta-analysis published online June 29 in the Cochrane Library.
Aug 2, 2017
0
0
(HealthDay)—A once-daily epilepsy drug may control seizures just as well as a twice-daily drug, researchers report.
Apr 14, 2016
0
36
New research shows that stomach sleepers with epilepsy may be at higher risk of sudden unexpected death, drawing parallels to sudden infant death syndrome in babies. The study is published in the January 21, 2015, online ...
Jan 21, 2015
0
576
(HealthDay)—Aptiom (eslicarbazepine acetate) has been approved by the U.S. Food and Drug Administration as an add-on drug to help treat adults with partial epileptic seizures.
Nov 11, 2013
0
0
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...
Jan 30, 2013
0
0
A Yale-led team of researchers has identified the gene that, when mutated, causes a devastating early-onset disorder in babies known as "malignant migrating partial seizures of infants," or MMPSI. The study appears online ...
Oct 24, 2012
0
0
Early-initiated immunotherapy appears to be associated with improved seizure outcomes among patients with autoimmune epilepsy, according to a report published Online First by Archives of Neurology.
Mar 26, 2012
0
0
